Hydrogen's Feasibility and Safety as a Therapy in ECPR
Recruiting
Phase 1
Interventional Study
Cardiac Arrest
Extracorporeal Membrane Oxygenation
Reperfusion Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 53 (estimated)
- Sponsor
- Boston Children's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this project is to test the feasibility and safety of inhaled hydrogen gas (H2) administration as a rescue therapy during cardiac arrest requiring extracorporeal cardiopulmonary resuscitation (ECPR, i.e. mechanical circulatory support). Under exemption from informed consent, patients undergoing refractory cardiac arrest in the cardiac ICU at a participating center will be randomized…
Trial Locations
Sorted by distance from Kentucky
Loading…
Loading trial locations…
Eligibility Criteria
INCLUSION CRITERIA
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
1. Patients admitted to a cardiac intensive care unit at a participating site with cardiac comorbidity, including congenital heart disease, myocarditis, cardiac arrhythmi…
Contacts
Victoria Habet, DO
CONTACT